Changyan Ma

1.2k total citations
49 papers, 945 citations indexed

About

Changyan Ma is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Changyan Ma has authored 49 papers receiving a total of 945 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 21 papers in Cancer Research and 8 papers in Oncology. Recurrent topics in Changyan Ma's work include Bone Metabolism and Diseases (13 papers), Cancer-related molecular mechanisms research (11 papers) and MicroRNA in disease regulation (7 papers). Changyan Ma is often cited by papers focused on Bone Metabolism and Diseases (13 papers), Cancer-related molecular mechanisms research (11 papers) and MicroRNA in disease regulation (7 papers). Changyan Ma collaborates with scholars based in China, United States and Denmark. Changyan Ma's co-authors include Yucui Jin, Jianlei Lü, Lintao Wang, Kaikai Shi, Jia‐Shu Yang, Hongwei Li, Da‐Peng Yang, Tianwei Gu, Bing Yao and Ting Wang and has published in prestigious journals such as PLoS ONE, Oncogene and FEBS Letters.

In The Last Decade

Changyan Ma

48 papers receiving 934 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Changyan Ma China 19 674 373 174 72 66 49 945
Gianmarco Rinaldi Belgium 14 661 1.0× 374 1.0× 91 0.5× 57 0.8× 114 1.7× 19 964
Moonmoon Deb India 23 873 1.3× 258 0.7× 153 0.9× 57 0.8× 29 0.4× 32 1.1k
Atsuhiro Kishimoto Japan 16 1.1k 1.6× 358 1.0× 245 1.4× 66 0.9× 35 0.5× 26 1.3k
Hyung‐Ok Lee United States 15 454 0.7× 261 0.7× 520 3.0× 131 1.8× 39 0.6× 27 1.1k
Huiwen Yan China 15 870 1.3× 553 1.5× 196 1.1× 140 1.9× 71 1.1× 24 1.2k
Noritaka Yamaguchi Japan 19 790 1.2× 318 0.9× 366 2.1× 130 1.8× 37 0.6× 53 1.2k
Zheng Jiang China 19 527 0.8× 211 0.6× 171 1.0× 111 1.5× 21 0.3× 36 974
Yuqing Zhang China 15 718 1.1× 340 0.9× 183 1.1× 115 1.6× 17 0.3× 22 1.0k

Countries citing papers authored by Changyan Ma

Since Specialization
Citations

This map shows the geographic impact of Changyan Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changyan Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changyan Ma more than expected).

Fields of papers citing papers by Changyan Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Changyan Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changyan Ma. The network helps show where Changyan Ma may publish in the future.

Co-authorship network of co-authors of Changyan Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Changyan Ma. A scholar is included among the top collaborators of Changyan Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Changyan Ma. Changyan Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Miao, Zhicheng Cao, Wenhui Hu, et al.. (2025). The Role of the Immune Microenvironment on Osteoblast Differentiation. Immunological Investigations. 54(7). 962–1011.
2.
Zhang, Ming, Cheng Tang, Shao‐Meng Li, et al.. (2025). NSUN2-mediated m5C modification of KDM6B mRNA enhances osteoclast differentiation and promotes breast cancer bone metastasis. Cancer Letters. 631. 217939–217939. 2 indexed citations
3.
Yan, Wenjing, Ying Li, W. Andy Tao, et al.. (2024). Chondrocyte‐Targeted Delivery System of Sortase A‐Engineered Extracellular Vesicles Silencing MMP13 for Osteoarthritis Therapy. Advanced Healthcare Materials. 13(16). e2303510–e2303510. 20 indexed citations
4.
Yao, Bing, Shang Li, Jingwan Zhou, et al.. (2023). EBF2 Links KMT2D‐Mediated H3K4me1 to Suppress Pancreatic Cancer Progression via Upregulating KLLN. Advanced Science. 11(2). e2302037–e2302037. 8 indexed citations
5.
Zhu, Zhu, et al.. (2023). Isopsoralen promotes osteogenic differentiation of human jawbone marrow mesenchymal cells through Notch signaling pathway. Annals of Anatomy - Anatomischer Anzeiger. 250. 152156–152156. 2 indexed citations
6.
Tang, Yuting, Liu Yang, Xiaoshu Zhu, et al.. (2023). ALKBH5-mediated m6A demethylation of HS3ST3B1-IT1 prevents osteoarthritis progression. iScience. 26(10). 107838–107838. 10 indexed citations
7.
Tang, Yuting, Siyang Ding, Jia‐Shu Yang, et al.. (2023). METTL3-mediated m6A modification of IGFBP7-OT promotes osteoarthritis progression by regulating the DNMT1/DNMT3a-IGFBP7 axis. Cell Reports. 42(6). 112589–112589. 18 indexed citations
8.
Chen, Yanlin, Yunfei Ma, Yuting Tang, et al.. (2023). DUSP1 promotes pancreatic cancer cell proliferation and invasion by upregulating nephronectin expression. ONCOLOGIE. 25(6). 681–690. 1 indexed citations
9.
Zhang, Ming, Jue Wang, Yucui Jin, et al.. (2022). YTHDF2-mediated FGF14-AS2 decay promotes osteolytic metastasis of breast cancer by enhancing RUNX2 mRNA translation. British Journal of Cancer. 127(12). 2141–2153. 26 indexed citations
10.
Yang, Ying, et al.. (2021). Insulin receptor is implicated in triple-negative breast cancer by decreasing cell mobility. Journal of Biomedical Research. 35(3). 189–189. 1 indexed citations
11.
Jin, Yucui, Ming Zhang, Rui Duan, et al.. (2020). Long noncoding RNA FGF14-AS2 inhibits breast cancer metastasis by regulating the miR-370-3p/FGF14 axis. Cell Death Discovery. 6(1). 103–103. 25 indexed citations
12.
Yao, Bing, Jue Wang, Shuang Qu, et al.. (2019). Upregulated osterix promotes invasion and bone metastasis and predicts for a poor prognosis in breast cancer. Cell Death and Disease. 10(1). 28–28. 25 indexed citations
13.
Wang, Lintao, et al.. (2015). Osthole inhibits proliferation of human breast cancer cells by inducing cell cycle arrest and apoptosis. Journal of Biomedical Research. 29(2). 132–132. 44 indexed citations
14.
Xu, Yuexin, Bing Yao, Kaikai Shi, et al.. (2015). Phosphorylation of Serine422 increases the stability and transactivation activities of human Osterix. FEBS Letters. 589(7). 857–864. 10 indexed citations
15.
Ma, Changyan. (2010). Expression of Osterix in Metastatic Breast Cancer Cells and Its Effects on MMP-2,MMP-9 and VEGF Promoter Activities. 1 indexed citations
16.
Yang, Da‐Peng, Tianwei Gu, Ting Wang, Qingjiu Tang, & Changyan Ma. (2010). Effects of Osthole on Migration and Invasion in Breast Cancer Cells. Bioscience Biotechnology and Biochemistry. 74(7). 1430–1434. 80 indexed citations
18.
Zhang, Jingjing, Changyan Ma, Xiao Han, Linda K. Durrin, & Yujie Sun. (2006). The bcl-2 major breakpoint region (mbr) possesses transcriptional regulatory function. Gene. 379. 127–131. 10 indexed citations
19.
Ma, Changyan, et al.. (2006). The BCL2 major breakpoint region (mbr) regulates gene expression. Oncogene. 26(18). 2649–2657. 32 indexed citations
20.
Sun, Yujie, Ting Wang, Yongmei Yin, et al.. (2005). The behavior of SATB1, a MAR‐binding protein, in response to apoptosis stimulation. Cell Biology International. 30(3). 244–247. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026